drugset / Trial / NCT03631017
Imaging With a PET Agent for Detection of Cancers of the Head and Neck
Non-randomizedParallel-groupOpen-labelDiagnostic
Summary
The purpose of this study is to test the safety of a study drug called PARPi-FL. This drug has been tested in animals but not yet in people. The purpose of this study is to test if a PARPi-FL scan can be used to take pictures of head and neck cancer. The usual approach to imaging this cancer includes several different imaging scans, including x-rays, CT (computed tomography), MRI (magnetic resonance imaging), and PET (positron emission tomography). These tests take pictures of the cancer.
Timeline
- Start
- 2018-08-10
- Primary completion
- 2026-08
- Completion
- 2026-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | PARPi-FL | Unknown | 100 ug | Other |
| Subject | PARPi-FL | Unknown | 370 mbq | Other |